Skip to main content
Equibles

Carrie Melvin

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Carrie Melvin

Earlier roles on record: COO at Viridian Therapeutics, Inc.\DE (VRDN) until April 11, 2023. Viridian Therapeutics, Inc.\DE reported in an 8-K filed April 12, 2023 that Carrie Melvin was terminated as Chief Operating Officer, effective April 11, 2023.

“On April 12, 2023, Viridian Therapeutics, Inc. (the "Company") announced that Carrie Melvin has ceased to serve as the Company's Chief Operating Officer, effective April 11, 2023.”
Viridian Therapeutics, Inc.\DE Form 8-K, filed April 12, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.